Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Epidural Anesthesia for Cesarean Delivery in a Parturient With Lumboperitoneal Shunt: A Case Report.

Moreno-Duarte I, Hall RR 3rd, Shutran MS, Radhakrishnan MG, Drzymalski DM.

A A Pract. 2019 Jun 15;12(11):436-437. doi: 10.1213/XAA.0000000000000960.

PMID:
30640273
2.

Monoamines in glioblastoma: complex biology with therapeutic potential.

Caragher SP, Hall RR, Ahsan R, Ahmed AU.

Neuro Oncol. 2018 Jul 5;20(8):1014-1025. doi: 10.1093/neuonc/nox210. Review.

3.

Cancer Stem Cells: Cellular Plasticity, Niche, and its Clinical Relevance.

Lee G, Hall RR 3rd, Ahmed AU.

J Stem Cell Res Ther. 2016 Oct;6(10). pii: 363. Epub 2016 Oct 26.

4.

Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions.

Kim J, Hall RR, Lesniak MS, Ahmed AU.

Viruses. 2015 Nov 27;7(12):6200-17. doi: 10.3390/v7122921. Review.

5.

Hair care practices as a barrier to physical activity in African American women.

Hall RR, Francis S, Whitt-Glover M, Loftin-Bell K, Swett K, McMichael AJ.

JAMA Dermatol. 2013 Mar;149(3):310-14.

PMID:
23682367
6.

Circumscribed alopecia: an unusual manifestation of pediculosis capitis.

Hall RR, McMichael AJ.

Pediatr Dermatol. 2012 Jul-Aug;29(4):513-4. doi: 10.1111/j.1525-1470.2011.01596.x. Epub 2011 Oct 20.

PMID:
22011127
7.

Hurdles in modern trial management: as overbureaucracy and commercialization of clinical trials suffocate independent academic research, it's time for a change.

Osanto S, van Poppel H, Burggraaf J, Hall RR.

Eur Urol. 2009 Oct;56(4):622-4. doi: 10.1016/j.eururo.2009.06.023. Epub 2009 Jun 23. No abstract available.

PMID:
19560861
8.

Unwanted palatal hair: a consequence of complex oropharyngeal reconstruction.

Hall RR, Pearce DJ, Brown T, McMichael AJ.

J Dermatolog Treat. 2009;20(3):149-51. doi: 10.1080/09546630802562450.

PMID:
19016375
9.

Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).

de Reijke TM, Kurth KH, Sylvester RJ, Hall RR, Brausi M, van de Beek K, Landsoght KE, Carpentier P; European Organization for the Research and Treatment of Cancer-Genito-Urinary Group.

J Urol. 2005 Feb;173(2):405-9.

PMID:
15643181
10.

Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumors.

Palou J, Laguna P, Millán-Rodríguez F, Hall RR, Salvador-Bayarri J, Vicente-Rodríguez J.

J Urol. 2001 May;165(5):1488-91.

PMID:
11342902
11.
12.

TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer.

Qureshi KN, Griffiths TR, Robinson MC, Marsh C, Roberts JT, Hall RR, Lunec J, Neal DE.

Clin Cancer Res. 1999 Nov;5(11):3500-7.

13.
14.
16.

Prostate cancer screening.

Hall RR, Alexander F.

J R Soc Med. 1998 Sep;91(9):507. No abstract available.

17.

Detecting and correcting hyperlipidemia.

Hall RR.

Hosp Pract (1995). 1998 Nov 15;33(11):83-90, 95-9; discussion 99-100, 102.

PMID:
9826960
18.

Screening for prostate cancer.

Hall RR.

Hosp Med. 1998 Jan;59(1):81. No abstract available.

PMID:
9798572
19.

The role of neoadjuvant or adjuvant chemotherapy for invasive bladder cancer Is there a benefit for survival or preserving the bladder?

Pavone-Macaluso M, Hall RR, Hirao Y, Kamidono S, Miyanaga N, de Mulder PH, Naito S, Shipley WU, Tsushima T.

Urol Oncol. 1998 Jul-Oct;4(4-5):154-67. No abstract available.

PMID:
21227221
20.

Bladder cancer.

Maffezzini M, Audisio R, Pavone-Macaluso M, Hall RR.

Crit Rev Oncol Hematol. 1998 Feb;27(2):151-3. Review. No abstract available.

PMID:
9571320
21.

Prostate cancer.

Repetto L, Granetto C, Hall RR.

Crit Rev Oncol Hematol. 1998 Feb;27(2):145-6. Review. No abstract available.

PMID:
9571318
22.

Application of clinical trials to the care of patients with bladder cancer.

Hall RR.

Eur Urol. 1997;31 Suppl 1:42-6. Review.

PMID:
9076485
23.

Estrogen replacement therapy after coronary angioplasty in women.

O'Keefe JH Jr, Kim SC, Hall RR, Cochran VC, Lawhorn SL, McCallister BD.

J Am Coll Cardiol. 1997 Jan;29(1):1-5.

24.

Neoadjuvant treatment for invasive bladder cancer: is it worthwhile?

Hall RR.

Acta Urol Belg. 1996 May;64(2):39-42. No abstract available.

PMID:
8701809
25.

Phase II trials in Ta, T1 bladder cancer. The marker tumour concept.

van der Meijden AP, Hall RR, Kurth KH, Bouffioux C, Sylvester R.

Br J Urol. 1996 May;77(5):634-7. Review. No abstract available.

PMID:
8689102
26.

The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up.

Tolley DA, Parmar MK, Grigor KM, Lallemand G, Benyon LL, Fellows J, Freedman LS, Grigor KM, Hall RR, Hargreave TB, Munson K, Newling DW, Richards B, Robinson MR, Rose MB, Smith PH, Williams JL, Whelan P.

J Urol. 1996 Apr;155(4):1233-8.

PMID:
8632538
27.

Chemoresection in Ta-T1 bladder cancer. Members of the EORTC Genito-Urinary Group.

Bono AV, Hall RR, Denis L, Lovisolo JA, Sylvester R.

Eur Urol. 1996;29(4):385-90.

PMID:
8791042
30.

Pain relief and quality-of-life assessment following intravenous and oral clodronate in hormone-escaped metastatic prostate cancer.

Cresswell SM, English PJ, Hall RR, Roberts JT, Marsh MM.

Br J Urol. 1995 Sep;76(3):360-5.

PMID:
7551847
31.
32.

The persistence of bacille Calmette-Guérin in the bladder after intravesical treatment for bladder cancer.

Bowyer L, Hall RR, Reading J, Marsh MM.

Br J Urol. 1995 Feb;75(2):188-92.

PMID:
7850324
33.
34.

Purchasers' view of localised prostate cancer management.

Hall RR.

Lancet. 1994 Oct 1;344(8927):956. No abstract available.

PMID:
7934368
36.

Superficial bladder cancer.

Hall RR.

BMJ. 1994 Apr 2;308(6933):910-3. Review.

37.
38.

Effects of chemotherapy on the kidney.

Cobos E, Hall RR.

Semin Nephrol. 1993 May;13(3):297-305. Review. No abstract available.

PMID:
8321929
39.

Interpretation of biopsies of "normal" urothelium in patients with superficial bladder cancer. MRC Superficial Bladder Cancer Sub Group.

Richards B, Parmar MK, Anderson CK, Ansell ID, Grigor K, Hall RR, Morley AR, Mostofi FK, Risdon RA, Uscinska BM.

Br J Urol. 1991 Apr;67(4):369-75.

PMID:
2032076
40.

Systemic chemotherapy for urothelial cancer in patients with ureteric obstruction.

Macneil HF, Hall RR, Neal DE, Roberts JT.

Br J Urol. 1991 Feb;67(2):169-72.

PMID:
2004230
41.

Staging of bladder cancer: is the tumor, node, metastasis system adequate?

Hall RR, Prout GR.

Semin Oncol. 1990 Oct;17(5):517-23. Review. No abstract available.

PMID:
2218563
42.

The epidermal growth factor receptor and the prognosis of bladder cancer.

Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL.

Cancer. 1990 Apr 1;65(7):1619-25.

PMID:
2311071
43.

The value of the bone scan.

Smith PH, Debruyne F, Armitage TG, Hall RR, Bono A, Denis L, Sylvester R.

Prog Clin Biol Res. 1990;357:53-7. No abstract available.

PMID:
2217478
44.

Radical TUR and chemotherapy aiming at bladder preservation.

Hall RR, Roberts JT, Marsh MM.

Prog Clin Biol Res. 1990;353:163-8. No abstract available.

PMID:
2217414
45.

Randomised intercontinental trial of locoregional therapy with or without neoadjuvant chemotherapy.

Hall RR, Parmar MK.

Prog Clin Biol Res. 1990;353:105-9. No abstract available.

PMID:
2217406
46.

Systemic chemotherapy in the management of advanced bladder cancer.

Hall RR.

Arch Esp Urol. 1990;43 Suppl 2:193-6. Review. No abstract available.

PMID:
2096778
47.

Characterization and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumors.

Smith K, Fennelly JA, Neal DE, Hall RR, Harris AL.

Cancer Res. 1989 Nov 1;49(21):5810-5.

48.

Epidermal growth factor receptor in human bladder cancer: a comparison of immunohistochemistry and ligand binding.

Neal DE, Smith K, Fennelly JA, Bennett MK, Hall RR, Harris AL.

J Urol. 1989 Mar;141(3):517-21.

PMID:
2783984
49.

Chemotherapy of advanced bladder cancer.

Hall RR, Roberts JT.

Prog Clin Biol Res. 1989;303:525-31. Review. No abstract available.

PMID:
2675009
50.

Urology and the TNM classification.

Hall RR, Beynon LL, Horwich A, Kaye S, Tolley D.

Lancet. 1988 Nov 12;2(8620):1145-6. No abstract available.

PMID:
2903362

Supplemental Content

Support Center